Amicus Therapeutics, Inc. (FOLD) stock saw a decline, ending the day at $9.31 which represents a decrease of $-0.11 or -1.17% from the prior close of $9.42. The stock opened at $9.48 and touched a low ...

Crowley's reputation for hard work and good fun earned him friends and respect for decades wherever he went in Greater ...

The event brings together biopharmaceutical professionals, government officials, academic leaders and professional service ...

Amicus Therapeutics, Inc. (FOLD) stock saw a modest uptick, ending the day at $9.84 which represents a slight increase of $0.04 or 0.41% from the prior close of $9.8. The stock opened at $9.73 and ...

President-elect Trump filed an amicus brief late Thursday in support of a legal effort by Texas and Missouri to "immediately" stop the Biden administration’s sale of border wall materials ...

In response, John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement: "Today’s decision by the U.S.-Mexico-Canada Agreement (USMCA) dispute ...

The team's hard work comes down to Saturday’s matchup at AT&T Stadium for the 6A high school football state title: North Crowley Panthers vs Austin Westlake.

Part romcom, part weepie, director John Crowley’s melodrama We Live in Time explores the relationship between chef Almut (Florence Pugh) and corporate lackey Tobias (Andrew Garfield). It was shot ...

We're delighted to welcome director John Crowley to introduce this preview of his new film. A decade-spanning deeply moving romance from the director of Brooklyn, We Live In Time follows Almut ...

Duncanville defensive end Colin Simmons (8) chases North Crowley quarterback Chris Jimerson Jr (12) out of bounds during the first half of a Class 6A Division I state semifinal football playoff ...

"It hasn't had a big movie profile, has it? And I think that's the point," director John Crowley told Digital Spy when asked about the Weetabix reference. "I directed a play by Nick [Payne] at the ...

The Elton John AIDS Foundation, which he started in 1992, was among the first and most high-profile organizations raising consciousness around the disease and money to combat it. His approach to ...